BioCentury
ARTICLE | Clinical News

Pivanex: Phase IIb completed enrollment

May 31, 2004 7:00 AM UTC

TTP completed enrollment of 225 patients in a Phase IIb trial comparing Pivanex plus Taxotere docetaxel from Aventis S.A. (AVE, Strasbourg, France) to docetaxel alone. ...